Passerini Nadia, Gavini Elisabetta, Albertini Beatrice, Rassu Giovanna, Di Sabatino Marcello, Sanna Vanna, Giunchedi Paolo, Rodriguez Lorenzo
Dipartimento di Scienze Farmaceutiche, Università di Bologna, Bologna, Italy.
J Pharm Pharmacol. 2009 May;61(5):559-67. doi: 10.1211/jpp/61.05.0003.
The aims of this study were to evaluate the suitability of the spray congealing technique to produce solid lipid microparticles (SLMs) for topical administration and to study the skin permeation of a drug from SLMs compared with solid lipid nanoparticles (SLNs).
Econazole nitrate was used as model drug and Precirol ATO 5 as the lipidic carrier. SLMs and SLNs were both prepared at 5:1, 10:1 and 12.5:1 lipid:drug weight ratios and characterised in terms of particle size, morphology, encapsulation efficiency and chemical analysis of the particle surface. SLMs and SLNs were also incorporated into HPMC K 100M hydrogels for ex-vivo drug permeation tests using porcine epidermis.
SLMs had particle sizes of 18-45 microm, while SLNs showed a mean diameter of 130-270 nm. The encapsulation efficiency was 80-100%. Permeation profiles of econazole nitrate were influenced by both particle size (significant difference until 9 h) and the amount of lipid.
The results confirm the usefulness of SLNs as carriers for topical administration and suggest the potential of SLMs for the delivery of drugs to the skin.
本研究旨在评估喷雾冷凝技术用于制备局部给药的固体脂质微粒(SLM)的适用性,并研究与固体脂质纳米粒(SLN)相比,药物从SLM中的皮肤渗透情况。
以硝酸益康唑为模型药物,Precirol ATO 5为脂质载体。分别以5:1、10:1和12.5:1的脂质:药物重量比制备SLM和SLN,并对其粒径、形态、包封率以及颗粒表面化学分析进行表征。还将SLM和SLN加入到HPMC K 100M水凝胶中,使用猪表皮进行体外药物渗透试验。
SLM的粒径为18 - 45微米,而SLN的平均直径为130 - 270纳米。包封率为80 - 100%。硝酸益康唑的渗透曲线受粒径(直到9小时存在显著差异)和脂质用量的影响。
结果证实了SLN作为局部给药载体的有效性,并表明SLM在将药物递送至皮肤方面的潜力。